ClinConnect ClinConnect Logo
Search / Trial NCT06891963

Transcutaneous Electrical Nerve Stimulation Versus Dry Needling in Non Specific Chronic Neck Pain

Launched by CAIRO UNIVERSITY · Mar 18, 2025

Trial Information

Current as of April 29, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at two different treatments for people suffering from non-specific chronic neck pain, which means neck pain that doesn’t come from a clear cause. The study compares Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (a gentle electrical treatment) with dry needling (a technique that involves inserting thin needles into specific points in the muscle) to see which method is more effective in reducing pain and improving neck function and movement.

To participate in this trial, individuals should be between 20 and 40 years old and have at least one active trigger point in their upper trapezius muscles (these are tight, painful spots in the neck area). Participants must also have had neck pain for 2 to 4 weeks and a normal neurological exam. However, those with certain medical conditions, such as severe spinal issues, recent physical therapy, or other specific health problems, will not be eligible. If you join the trial, you can expect to receive one of the treatments and help researchers understand which is better for relieving neck pain. The trial is not yet recruiting, so stay tuned for updates if you're interested!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Having at least 1 active trigger point in upper trapezius muscles will use a recommended diagnostic criterion to find active MTrPs which is:
  • The presence of a palpable taut band in the skeletal muscle.
  • The presence of a hypersensitive spot in the taut band.
  • Local twitch response provoked by snapping palpation.
  • Production of a typical referred pain pattern in response to the compression of tender spots.
  • Spontaneous presence of the typical referred pain pattern.
  • Duration of symptoms of acute stage (2-4) weeks.
  • Age between (20-40) years.
  • Having a normal neurological examination result .
  • Exclusion Criteria:
  • Existence of cervical disc hernia, advanced cervical osteoarthritis, radiculopathy, or myelopathy.
  • Having trigger point injection or physical therapy in the last 6 months.
  • Having a rheumatologic disease, such as fibromyalgia, rheumatoid arthritis, or a hormonal disease, such as hypothyroidism, hyperthyroidism or hyperparathyroidism.
  • Existence of kyphosis, scoliosis, forward head posture or cervicogenic headache.
  • History of spine surgery.
  • Having a cardiovascular problem.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Zagazig, , Egypt

Patients applied

0 patients applied

Trial Officials

Neveen Abdel Latif Abdel Raoof, PhD

Study Chair

Professor, Cairo university

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported